Administration, Intravaginal
"Administration, Intravaginal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories.
| Descriptor ID |
D000282
|
| MeSH Number(s) |
E02.319.267.120.500
|
| Concept/Terms |
Administration, Intravaginal- Administration, Intravaginal
- Vaginal Administration
- Administrations, Vaginal
- Vaginal Administrations
- Administration, Vaginal
- Intravaginal Administration
- Administrations, Intravaginal
- Intravaginal Administrations
Instillation, Vaginal- Instillation, Vaginal
- Instillations, Vaginal
- Vaginal Instillation
- Vaginal Instillations
- Vaginal Drug Administration
- Drug Administration, Vaginal
- Administration, Vaginal Drug
- Administrations, Vaginal Drug
- Drug Administrations, Vaginal
- Vaginal Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Intravaginal".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intravaginal".
This graph shows the total number of publications written about "Administration, Intravaginal" by people in this website by year, and whether "Administration, Intravaginal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Intravaginal" by people in Profiles.
-
Constantine GD, Graham S, Lapane K, Ohleth K, Bernick B, Liu J, Mirkin S. Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review. Menopause. 2019 07; 26(7):800-807.
-
Nasioudis D, Kim SW, Schoen C, Levine LD. Maternal and neonatal outcomes with mechanical cervical dilation plus misoprostol compared to misoprostol alone for cervical ripening; a systematic review of literature and metaanalysis. Am J Obstet Gynecol MFM. 2019 05; 1(2):101-111.
-
Schoen CN, Grant G, Berghella V, Hoffman MK, Sciscione A. Intracervical Foley Catheter With and Without Oxytocin for Labor Induction: A Randomized Controlled Trial. Obstet Gynecol. 2017 06; 129(6):1046-1053.
-
Schoen CN, Tabbah S, Iams JD, Caughey AB, Berghella V. Why the United States preterm birth rate is declining. Am J Obstet Gynecol. 2015 Aug; 213(2):175-80.
-
Fontenot HB, Fantasia HC. Vaginal progesterone to prevent preterm birth in high-risk women. Nurs Womens Health. 2012 Jun-Jul; 16(3):237-41.
-
Camp EA, Coker AL, Troisi R, Robboy SJ, Noller KL, Goodman KJ, Titus-Ernstoff LT, Hatch EE, Herbst AL, Kaufman RH, Adam E. Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. J Low Genit Tract Dis. 2008 Apr; 12(2):111-7.
-
Wang Y, Abel K, Lantz K, Krieg AM, McChesney MB, Miller CJ. The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J Virol. 2005 Nov; 79(22):14355-70.
-
Kessel B, Nachtigall L, Plouffe L, Siddhanti S, Rosen A, Parsons A. Effect of raloxifene on sexual function in postmenopausal women. Climacteric. 2003 Sep; 6(3):248-56.
-
Pinkerton JV, Shifren JL, La Valleur J, Rosen A, Roesinger M, Siddhanti S. Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women. Menopause. 2003 Jan-Feb; 10(1):45-52.
-
Grow DR. Metabolism of endogenous and exogenous reproductive hormones. Obstet Gynecol Clin North Am. 2002 Sep; 29(3):425-36.